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Danshen: A Popular
Chinese Cardiac Herbal Drug
The recently published document in JACC on complementary and
integrative medicine (1) left out one very important herbal drug,
danshen. Because it is believed to have properties of improving
microcirculation, increasing coronary blood flow, suppressing
thromboxane formation, inhibiting platelet adhesion and aggrega-
tion, and protecting against myocardial ischemia (2), it is used
either alone or in combination with other herbal ingredients for
patients with coronary artery disease (CAD), in both China and
other countries, including the U.S.
Conversely, danshen also interacts with warfarin by potentiating
its anticoagulant action (3). Because both warfarin usage and CAD
are so common in everyday cardiologic practice, the possibility of
the interaction between warfarin and danshen should be kept in
mind when excessive bleeding or unexpected prolongation of the
prothrombin time or international normalized ratio is encountered
in any patient on warfarin who has otherwise been under good
anticoagulant control. Because danshen is a common compound of
many cardiotonic herbal preparations, patients oftentimes may not
be aware that they are actually taking it. Furthermore, danshen can
be administered not only as an oral tablet but also in a nebulizer
(4). It has even been incorporated into some Chinese-brand
cigarettes (5), so that many cigarette smokers may not even be
aware of its presence.
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Complementary Medicine Has
No Place in Cardiovascular Medicine
The recent American College of Cardiology Foundation (ACCF)
Complementary Medicine Expert Consensus Document—
“Integrating Complementary Medicine Into Cardiovascular Med-
icine (1)”—presents problems for science-based physicians who
demand evidence-based medicine. Complementary medicine im-
plies that alternative medicine modalities are performed as an
adjunct to Western medicine. There is, however, no place for
unproven, unscientific (alternative) medicine in cardiovascular
medicine. Alternative medicine practitioners attempt to skirt the
unscientific nature of their unproven therapies by adding some
therapies that have always been considered conventional—exercise,
diets, physical therapy modalities, and relaxation prescriptions.
The Institute of Medicine (IOM) report (2) referred to in the
ACCF Document argues that the true complementary and alter-
native medicine practices (chiropractic, acupuncture, naturopathy,
homeopathy, and no doubt hundreds more) are rooted in forms of
evidence and logic other than those used in biomedical sciences. I
(3) and others have suggested that this constitutes the “free-ride”
of alternative medicine.
The ACCF document points out the deficiencies and lack of
evidence for most dietary supplements and herbs. I can think of
little if any place for herbs and supplements in modern cardiovas-
cular medicine. Today, we use digoxin, not the foxglove. Sampson
(4), in his discussion of herbal remedies and basically all alternative
remedies, suggests that they “are generally less effective or ineffec-
tive, and randomized clinical trials of these remedies measure
mostly subjective symptoms. . . . Inconsistent outcome from stud-
ies of alternative treatments seem to be the norm.”
The ACCF document alludes to the problems related to
chelation therapy, but it fails to criticize the launching of still
another expensive trial of that repeatedly disproved therapy.
Sampson suggests that, as scientists, we will not go astray by
supporting a medicine based on evidence that has passed through
the sieve of plausibility and that is consistent with basic sciences,
other applied sciences, and history—all molded by wisdom and
common sense.
The most glaring deficiency of the ACCF report is in the
lengthy section on acupuncture, which suggests that there is
evidence of value and potential indications for this alternative
therapy. A recent review by Atwood (5) claims that “investigations
of acupuncture to date have not demonstrated effects on the natural
history of any disease.” I know of no proven value for acupuncture
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in cardiovascular medicine. Acupuncture and especially “electro-
acupuncture” has wonderful placebo capabilities. Positive effects
from acupuncture can be attributed to psychosomatic mechanisms
related to conditioning, expectation, suggestion, and distraction
from the actual source of the pain or discomfort. Acupuncture, like
much of Chinese medicine, is based on mysticism—belief in that
which cannot be proven and unable to be understood.
In summary, there is no place for complementary medicine in
cardiovascular medicine.
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REPLY
In his letter to the editor regarding our document on “Integrating
Complementary Medicine Into Cardiovascular Medicine” (1), Dr.
Bartecchi states complementary medicine has no place in cardio-
vascular medicine. “No place for it?” This is not our choice in that
more than a majority of patients already are using complementary
and alternative medicine (CAM) therapy. In fact, over 50% of all
Americans are seeking the help of an alternative health care
practitioner, which in past years has represented over 600 million
visits and nearly $40 billion. Consequently, our effort with this
document was to put the emerging area of CAM treatment and
investigation into focus in order to enable the physician to provide
better patient care in a meaningful and safe manner. Whether the
physician believes or does not believe in CAM, it is important that
he or she is familiar with CAM so as to provide complete care to
the patient and be aware of many good and bad interactions, such
as with various supplements and herbs.
The “free ride” of CAM is a fact for most medical therapeu-
tics—a minority of clinical practices are actually supported by class
IA guidelines. Our intent is to stimulate more rigorous and
informative research investigations of the safety and effectiveness
of CAM therapies in cardiovascular care, with an emphasis on
safety.
At the present time, chelation therapy is neither proven nor
unproven, and there may be dangers. Clearly, this area deserves a
careful randomized study now in progress (TACT) and sponsored
by the National Institutes of Health (NIH) in order to resolve the
role of chelation therapy.
Dr. Bartecchi criticizes acupuncture, stating that electro-
acupuncture has wonderful placebo capabilities, and positive effects
of acupuncture can be related to psychosomatic mechanisms—
opinions that are not only not referenced but also unfounded.
Clearly, all treatments in medicine, whether allopathic or integra-
tive, have a placebo component that can contribute to as much as
30% to 40% of a clinical response. Our document provides
evidence supporting a neurophysiologic basis for the influence of
acupuncture in a number of diseased conditions including pain,
nausea and vomiting, and certain cardiovascular conditions such as
hypertension and myocardial ischemic symptoms, including angina
pectoris. These studies support a role for the endogenous opioid
system and other modulatory neurotransmitters that are activated
by acupuncture and inhibit the action of excitatory neurotransmit-
ters such as glutamate in regions of the brain concerned with
cardiovascular regulation. These regions include the rostral-
ventral-lateral medulla, the periaqueductal gray, and the arcuate
nucleus, among others. Electro-acupuncture causes very similar
effects to manual acupuncture as shown recently in the Journal of
Applied Physiology. Instead of quoting reports published by the
Scientific Review of Alternative Medicine, which, in fact, performs
no independent scientific study of this emerging area of medicine,
we would strongly encourage Dr. Bartecchi to review the high-
quality scientific literature that has been published on the mech-
anisms by which acupuncture can regulate the cardiovascular
system. Such studies are supported by the National Institutes of
Health, the Heart, Lung, and Blood Institute, and have been
published in journals such as Circulation; The American Journal of
Physiology; The Journal of Applied Physiology; Neuroscience; Brain
Research; and Autonomic Neuroscience: Basic & Clinical.
We appreciate the comments by Dr. Cheng regarding the
Chinese herbal drug danshen. We were not able to include
everything in our first document, but clearly it is important to
understand that danshen may affect hemostasis, including inhibi-
tion of platelet aggregation, interference with extrinsic blood
coagulation and antithrombin III-like activity, and promotion of
fibrinolytic activities. Certainly patients receiving warfarin therapy
may present with gross over-anticoagulation and bleeding compli-
cations with danshen, and because of these effects it should be
avoided in patients taking warfarin or antiplatelet drugs.
In our report we made a strong effort to familiarize physicians
with the actions of various herbs and supplements, not only in their
benefits, but also the many dangers and interactions that can occur
and with which the physician should be familiar. Unfortunately,
various surveys have indicated that many patients do not share the
information as to the herbs and supplements they are taking
because they feel the physician is not interested. Consequently,
because of this, various dangers, interactions, and consequences
have occurred. It is important for the physician to inquire of
patients about all medications they are taking, including herbs and
supplements. See Appendix 5 in the document on www.acc.org.
In summary, as stated in our document, our purpose has been to
familiarize cardiologists with widely employed complementary
medical practices. For the most part, our document is neither an
endorsement nor a recommendation of specific practices; rather, it
is a resource for those practitioners wishing to learn about these
techniques, and, thus, enable them to provide meaningful solid
doctor–patient relationships with a commitment to the core
mission of caring for patients on a physical, mental, and spiritual
level.
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